skip to main content

    Updated Visitor Guidelines

 

MENU

 

The importance of reducing heart exposure during radiation treatment

A team at the University of Michigan Health Rogel Cancer Center, in partnership with the statewide Michigan Radiation Oncology Quality Consortium, or MROQC, lung cancer collaborative, co-led by Shruti Jolly, M.D., and Peter Paximadis, M.D., of Spectrum Health Lakeland in St. Joseph, Michigan, found that raising awareness about the risk of radiation exposure to the heart and standardizing cardiac exposure limits reduced the average dose to the heart by 15% and reduced the number of patients receiving the highest heart doses by half without minimizing tumor treatment or increasing dosage to other at-risk organs in the chest.

Researchers use artificial intelligence to learn the effectiveness of bladder cancer treatment

By using an artificial intelligence-based system, researchers improved doctors' assessment of whether patients with bladder cancer had a complete response to chemotherapy before undergoing a radical cystectomy (bladder cancer removal surgery).

Research shows side effects of radiation therapy are reduced when computer optimizes treatment

When a computer optimized the treatment plan for radiation therapy that was broken into multiple segments, known as inverse-planned, intensity-modulated radiotherapy, or IMRT, breast cancer patients were in less pain and experienced less skin irritation than when CT scans were used to deliver three-dimensional conformal radiation therapy, also know as 3DCRT.

Rogel Cancer Center announces new cancer health equity scholars, plus other 2022 awards

The University of Michigan Rogel Cancer Center will provide funding support to 12 exceptional faculty researchers, 2 early career clinical researchers and six medical and graduate students. In addition, the center has launched a new program for Rogel Scholars in Cancer Health Equity, to support two faculty members who are working to address the cancer burden in historically underserved or excluded populations.

Tumors partially destroyed with sound don’t come back

Noninvasive sound technology developed at the University of Michigan breaks down liver tumors in rats, kills cancer cells and spurs the immune system to prevent further spread—an advance that could lead to improved cancer outcomes in humans.

Emerging Leaders set the agenda for next generation

The Emerging Leaders Council (ELC) is comprised of 15 early career faculty members interested in taking a larger role in the cancer center. Candidates are selected by the SLC and serve 3-year terms. The council is led by a chair, and two co-chairs elected by the ELC members to serve one-year terms.

Mammogram screenings beginning at age 40 would reduce cancer deaths for Black Women

The research, published in Annals of Internal Medicine, suggests that a reduction in breast cancer deaths can be achieved for Black women while maintaining the same ratio of benefits to harms that occurs when white women undergo screening every other year starting at age 50.

Melanoma referral centers worldwide adopt systemic therapies

The surgeons at 21 melanoma referral centers collaborated to see whether these revelations had created changes in treatment plans for high-risk melanoma. It can often take significant time — as long as a decade — for providers to adopt or deescalate cancer treatments, even if the available evidence supports a shift in the landscape.

Pages